Covid, immunoglobulins, malaria and Artemisia
Malaria schützt gegen Covid
Congratulations for Jerome Munyangi who with other Africans run the successful large scale double blind clinical trials in RDC against malaria and bilharzia, confirming previous smaller clinical trials run in other countries by African medical teams. Everybody wants to find Artemisia now for infusions against Covid and Malaria. Several of our partners in Africa are confronted with a stockout. Several newspapers or blogs confirm that malaria endemic regions are virtually Covid free. They relate this to malaria drugs. We rather are of the opinion that it is due to acquired immunity, immunoglobulins and their enhancement by Artemisia infusions (not artemisinin or ACTs). Mosquito-borne diseases are associated with major global health burdens. In a recent paper: J Munyangi, P Ogwang, P Gisenya, P Lutgen. An unexpected, revolutionary property of Artemisia infusions. Pharm Pharmacol Int J. 2020;8(1):46‒62. the authors describe how the saliva of mosquitoes during parasite or virus infection may affect transmission. For their blood meal mosquitoes inject saliva. Reactions to mosquito bites, lead to immunological reactions, to swelling, wheal and flare of the skin. Mosquito saliva contains many biological materials, anticlotting and antiplatelet factors and vasodilators which presumably increase the speed at which blood from the host is imbibed. But also, immunomodulators, allergens which bind to IgE and induce histamine and iNOS release. Allergens are present in the saliva of most of the mosquitoes, even in those which are not infected. A study has shown in a murine model that bites from uninfected mosquitoes prior to Plasmodium yoelii infection influence the local and systemic immune responses and limit parasite development within the host. And it may explain why people living in countries with dense Anopheles populations are immunized by these bites. A similar phenomenon has been noticed for other diseases: repeated infestation with Ixodes scapularis ticks induces resistance to Borrelia burgdorferi transmission. And multiple exposure to bites from uninfected sand flies prior to infection confer resistance to Leishmania major. Aedes spp. and Culex spp. are primarily responsible for the transmission of the most medically important viruses, including dengue virus, West Nile virus and Zika virus. Despite the burden of these pathogens on human populations, the interactions between viruses and their hosts remain enigmatic, especially during the transmission phase from mosquito to human host. Some authors find that the saliva of the bite increases virus replication, others that it is inhibited : Tonnerre P, Melgaço JG. Evolution of the innate and adaptive immune response in women with acute Zika virus infection. Nat Microbiol. 2020 Jan;5(1):76-83 Garcia M, Alout H. Innate Immune Response of Primary Human Keratinocytes to West Nile Virus Infection and Its Modulation by Mosquito Saliva. Front Cell Infect Microbiol. 2018 Nov 2; 8:387 Vogt MB, Lahon A, Arya RP. (2018) Mosquito saliva alone has profound effects on the human immune system and increases the frequency of CD4+CD8+ double positive T cells and natural killer T cells. PLoS Negl Trop Dis 2018, 12(5): e0006439 A few decades ago, the almost complete absence of infectious HIV in saliva was noticed. Inhibition of HIV may be partly due to several inhibitors of viruses that are present in the saliva. Inhibitory factors to human immunodeficiency virus type 1 (HIV-1) in saliva may be responsible for the infrequent isolation of virus from saliva and also may account for the marked infrequency of salivary and/or oral transmission of HIV-1. Incubation of HIV-1 with human saliva followed by addition of the mixture to susceptible cells leads to partial or complete suppression of viral replication in vitro. Malamud D, Abrams WR, Barber CA. Antiviral Activities in Human Saliva. Adv Dent Res. 2011 Apr; 23(1): 34–37. DW Archibald, GA Cole In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses, 1990:6, 1425-32 Philip C. Fox, Saliva inhibits HIV-1 infectivity. J Am Dental Assoc, 1988 Volume 116, 6,635–637 Fultz PN Components of saliva inactivate human immunodeficiency virus. Lancet. 1986; 2:1215 It is possible that people living in malaria endemic areas are immunized against Covid-19, • either by the saliva injected in frequent mosquito bites; some of its constituents remain for days or weeks in the skin and in the body • or by the development of specific immunoglobulins.